{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Camarillo",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "81500",
      "recalling_firm": "Golden State Medical Supply Inc.",
      "address_1": "5187 Camino Ruiz",
      "address_2": "N/A",
      "postal_code": "93012-8601",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed throughout the United States.",
      "recall_number": "D-0263-2019",
      "product_description": "IRBESARTAN Tablets, USP 75 mg 90-count bottle, Rx Only, Manufactured by: SciGen Pharmaceuticals, Inc. Hauppauge, NY 11788, Distributed by: GSMS, Incorporated, Camarillo, CA 93012, USA,  NDC 60429-640-90.",
      "product_quantity": "2,439 bottles",
      "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine (NDEA) in product.",
      "recall_initiation_date": "20181102",
      "center_classification_date": "20181120",
      "termination_date": "20200916",
      "report_date": "20181128",
      "code_info": "Lot Numbers:   B160003; Exp. 09/19  B160004; Exp. 09/19",
      "more_code_info": ""
    }
  ]
}